<?xml version="1.0" encoding="UTF-8"?>
<rss version="2.0"
	xmlns:content="http://purl.org/rss/1.0/modules/content/"
	xmlns:wfw="http://wellformedweb.org/CommentAPI/"
	xmlns:dc="http://purl.org/dc/elements/1.1/"
	xmlns:atom="http://www.w3.org/2005/Atom"
	xmlns:sy="http://purl.org/rss/1.0/modules/syndication/"
	xmlns:slash="http://purl.org/rss/1.0/modules/slash/"
	>

<channel>
	<title>Stock Blog Hub &#187; CSCX</title>
	<atom:link href="http://www.stockbloghub.com/tag/cscx/feed" rel="self" type="application/rss+xml" />
	<link>http://www.stockbloghub.com</link>
	<description>Start Your Investing Research Here!</description>
	<lastBuildDate>Tue, 22 May 2012 18:53:06 +0000</lastBuildDate>
	<language>en</language>
	<sy:updatePeriod>hourly</sy:updatePeriod>
	<sy:updateFrequency>1</sy:updateFrequency>
	<generator>http://wordpress.org/?v=3.3.2</generator>
		<item>
		<title>(ZOLL) ZOLL Medical Corporation Analysts Downgrade to Neutral</title>
		<link>http://www.stockbloghub.com/2010/01/13/zoll-zoll-medical-corporation-analysts-downgrade-to-neutral/24896</link>
		<comments>http://www.stockbloghub.com/2010/01/13/zoll-zoll-medical-corporation-analysts-downgrade-to-neutral/24896#comments</comments>
		<pubDate>Wed, 13 Jan 2010 23:59:10 +0000</pubDate>
		<dc:creator>vitalstocks</dc:creator>
				<category><![CDATA[Healthcare]]></category>
		<category><![CDATA[Medical Appliances & Equipment]]></category>
		<category><![CDATA[Cardiac Science Corporation]]></category>
		<category><![CDATA[CSCX]]></category>
		<category><![CDATA[Koninklijke Philips Electronics NV]]></category>
		<category><![CDATA[MDT]]></category>
		<category><![CDATA[Medtronic Inc]]></category>
		<category><![CDATA[PHG]]></category>
		<category><![CDATA[ZOLL]]></category>
		<category><![CDATA[Zoll Medical Corporation]]></category>

		<guid isPermaLink="false">http://www.stockbloghub.com/?p=24896</guid>
		<description><![CDATA[We have downgraded ZOLL Medical Corporation (ZOLL) to Neutral from Outperform with a price target of $29.50. Even though we are pleased with the company’s significant international presence &#8212; which coupled with its wide range of products also drive growth &#8211; the intense competition confronting its products concern us. Furthermore, ZOLL’s strategy of growth by acquisition has inherent risks. Headquartered in Chelmsford, Massachusetts, and founded in 1980, ZOLL Medical Corporation designs, manufactures, markets and sells non-invasive resuscitation devices and related software solutions both in the U.S. and overseas. The solutions include defibrillation devices with/without the pacing option, such as ZOLL&#8217;s M Series, E Series, R Series, automated external defibrillator (AED) Plus, AED Pro, and LifeVest Wearable Defibrillator. Furthermore, these solutions include a circulatory assist device called AutoPulse. The product pipeline also ]]></description>
		<wfw:commentRss>http://www.stockbloghub.com/2010/01/13/zoll-zoll-medical-corporation-analysts-downgrade-to-neutral/24896/feed</wfw:commentRss>
		<slash:comments>0</slash:comments>
		</item>
		<item>
		<title>(ZOLL) ZOLL Medical Beats Expectations in Recent Quarter</title>
		<link>http://www.stockbloghub.com/2009/11/12/zoll-zoll-medical-beats-expectations-in-recent-quarter/20374</link>
		<comments>http://www.stockbloghub.com/2009/11/12/zoll-zoll-medical-beats-expectations-in-recent-quarter/20374#comments</comments>
		<pubDate>Thu, 12 Nov 2009 16:17:24 +0000</pubDate>
		<dc:creator>vitalstocks</dc:creator>
				<category><![CDATA[Healthcare]]></category>
		<category><![CDATA[Medical Appliances & Equipment]]></category>
		<category><![CDATA[Cardiac Science Corporation]]></category>
		<category><![CDATA[CSCX]]></category>
		<category><![CDATA[Koninklijke Philips Electronics NV]]></category>
		<category><![CDATA[PHG]]></category>
		<category><![CDATA[ZOLL]]></category>
		<category><![CDATA[Zoll Medical Corporation]]></category>

		<guid isPermaLink="false">http://www.stockbloghub.com/?p=20374</guid>
		<description><![CDATA[ZOLL Medical Corp. (ZOLL) reported fourth-quarter earnings of 16 cents per share, which beat the Zacks Consensus Estimate of 8 cents. The company earned 41 cents in the year-ago quarter. The lower profit in the quarter was attributable to lower margins coupled with higher expenses, in spite of higher revenues. For full fiscal 2009, the company earned 45 cents per share, which exceeded the Zacks Consensus Estimate by 8 cents but was well below the year-ago earnings of $1.10. Quarterly Results Revenues in the reported quarter came in at $107.87 million from $105.60 million in the year ago quarter, up 2%. Revenue for the quarter reflected a negative foreign exchange impact of approximately $1.4 million and included approximately $5 million from the acquisition of the Temperature Management business. Sales in ]]></description>
		<wfw:commentRss>http://www.stockbloghub.com/2009/11/12/zoll-zoll-medical-beats-expectations-in-recent-quarter/20374/feed</wfw:commentRss>
		<slash:comments>0</slash:comments>
		</item>
	</channel>
</rss>

